1[1]Schroeder KW. Role of mesalazine in acute and long- term treat ment of ulcerative colitis and its complications. Scand J Gastroen terol Suppl,2002,236:42-47
2[2]McKeage K,Goa KL. Budesonide (Entocort EC Capsules): a re view of its therapeutic use in the management of active Crohn's disease in adults. Drugs,2002,62(15):2263-2282
3[3]Lindgren S,Lofberg R,Bergholm L,et al. Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis. Scand J Gastroenterol,2002,37(6):705-710
4[4]Hanauer SB. Inflammatory bowel disease. In: Bennett JC,Plum Feds. Cecil Textbook of Medicine. 20ed. Philadelphia:Saunders Company,1996: 707-715
5[5]Louis E,Belaiche J. Optimizing treatment with thioguanine deriva tives in inflammatory bowel disease. Best Pract Res Clin Gastroen terol,2003,17(1):37-46
6[6]Bonaz B,Boitard J,Marteau P,et al. Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptop urine. Aliment Pharmacol Ther,2003,18(4):401-408
7[7]Shanahan F. Inflammatory bowel disease: immunodiagnostics,im munotherapeutics and ecotherapeutics. Gastroenterology,2001,120(3):622-635
8[8]D Haens G,Lemmens L,Geboes K,et al. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology,2001,120(6):1323-1329
9[9]Fellermann K,Tanko Z,Herrlinger KR,et al. Response of re fractory colitis to intravenous or oral tacrolimus (FK506). Inflamm Bowel Dis,2002 ,8(5):317-324
10[10]Neurath MF,Wanitschke R,Peters M,et al. Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease. Gut,1999,44(5):625-628
